MitoQ has unveiled a dietary supplement named Hormonal Metabolic Control. This innovation is specifically formulated for women navigating perimenopause and menopause.
MitoQ’s Hormonal Metabolic Control targets the relationship between declining estrogen levels and metabolic shifts. Sympyoms include changes in energy, digestion, fat distribution around the midsection, and blood sugar balance. The core ingredient is S-Equol, a plant-derived compound that acts as a phytoestrogen to support healthy estrogen signalling during periods of fluctuation, which is then paired with the probiotic Bifidobacterium breve to address gut comfort and the gut-hormone connection. Chromium is added to help maintain already-normal blood glucose levels and insulin signalling.
MitoQ references clinical data, suggesting that users may observe reductions in symptoms associated with estrogen decline within ninety days, as well as improvements in metabolic markers after twelve weeks.
Image Credit: MitoQ